High expression of L-type amino acid transporter 1 in infiltrating glioma cells

被引：58

作者：

Nawashiro H. ^{[1
]}

Otani N. ^{[1
]}

Uozumi Y. ^{[1
]}

Ooigawa H. ^{[1
]}

Toyooka T. ^{[1
]}

Suzuki T. ^{[1
]}

Katoh H. ^{[1
]}

Tsuzuki N. ^{[1
]}

Ohnuki A. ^{[1
]}

Shima K. ^{[1
]}

Shinomiya N. ^{[2
]}

Matsuo H. ^{[3
]}

Kanai Y. ^{[4
]}

机构：

[1] Department of Neurosurgery, National Defense Medical College, Tokorozawa, Saitama 359-8513

[2] Department of Microbiology, National Defense Medical College, Saitama

[3] 1st Department of Physiology, National Defense Medical College, Saitama

[4] Department of Pharmacology and Toxicology, Kyorin University, School of Medicine, Tokyo

来源：

Brain Tumor Pathology | 2005年 / 22卷 / 2期

关键词：

Glioma; Immunohistochemistry; LAT1;

D O I：

10.1007/s10014-005-0188-z

中图分类号：

学科分类号：

摘要：

L-type amino acid transporter 1 (LAT1), a neutral amino acid transport agent, is essential for the transport of large neutral amino acids. LAT1 also corresponds to tumor-associated gene-1 (TA1), an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. We have investigated the expression of the transporter in the human primary glioma tissue from 68 patients. Among these patients, we could see the border zone between tumors and normal bain tissues in 10 patients. By WHO criteria, two of the specimens were diagnosed as grade 2, three as grade 3, and five as grade 4 [glioblastoma multiforme (GBM)]. In 9 of 10 cases, we could identify the infiltrating glioma cells associated with stronger immunoreactivity for LAT1. These tumor cells aggregated around the neurons in the border zone and were often found in the perivascular space. In one GBM case, the tumors seemed to develop expansively and separated from the normal brain with a border of arachnoid membrane. The expression of LAT1 was always higher in infiltrating glioma cells than in cells located in the center of the tumor. These findings suggest that LAT1 is one of the molecular targets for glioma therapy. © 2005 The Japan Society of Brain Tumor Pathology.

引用

页码：89 / 91

页数：2

共 10 条

[1]

Kanai Y., Segawa H., Miyamoto K., Et al., Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98), J Biol Chem, 273, pp. 23629-23632, (1998)

[2]

Nawashiro H., Otani N., Shinomiya N., Et al., The role of CD98 in astrocytic neoplasms, Hum Cell, 15, pp. 25-31, (2002)

[3]

Mannion B.A., Kolesnikova T.V., Lin S.H., Et al., The light chain of CD98 is identified as E16/TA1 protein, J Biol Chem, 273, pp. 33127-33129, (1998)

[4]

Kleihues P., Cavenee W.K., Pathology and Genetics of Tumours of the Nervous System, (2000)

[5]

Matsuo H., Tsukada S., Nakata T., Et al., Expression of a system L neutral amino acid transporter at the blood-brain barrier, Neuroreport, 11, pp. 3507-3511, (2000)

[6]

Christensen H.N., Role of amino acid transport and countertransport in nutrition and metabolism, Physiol Rev, 70, pp. 43-77, (1990)

[7]

Kuwert T., Probst-Cousin S., Woesler B., Et al., Iodine-123-methyltyrosine in gliomas: Correlation with cellular density and proliferative activity, J Nucl Med, 38, pp. 1551-1555, (1997)

[8]

Kaschten B., Stevenaert A., Sadzot B., Et al., Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine, J Nucl Med, 39, pp. 778-785, (1998)

[9]

Langen K.J., Bonnie R., Muhlensiepen H., Et al., 3-[<sup>123</sup>I]iodo-alpha-methyl-l-tyrosine transport and 4F2 antigen expression in human glioma cells, Nucl Med Biol, 28, pp. 5-11, (2001)

[10]

Shikano N., Kanai Y., Kawai K., Et al., Characterization of 3-[<sup>125</sup>I]iodo-alpha-methyl-l-tyrosine transport via human L-type amino acid transporter 1, Nucl Med Biol, 30, pp. 31-37, (2003)

← 1 →